CAMLINFINE NSE filing

Camlin Fine Sciences Files Certificate Under SEBI (Depositories and Participants) Regulations, 2018

The RealCase readLow impact Neutral

Camlin Fine Sciences Limited submitted a SEBI compliance certificate for Q1 FY27, received from its registrar MUFG Intime India Private Limited. The certificate confirms processing of dematerialised securities for the quarter ended June 30, 2026.

Why it matters

This is a standard regulatory filing that does not contain any new material information about the company's financial performance, strategic decisions, or operational changes. Therefore, its impact on the stock price is expected to be minimal.

The market read

The announcement is a routine compliance filing regarding the processing of dematerialised securities and does not contain any new financial or business-related information that would impact the company's valuation.

Camlin Fine Sciences Limited has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended June 30, 2026. The company received this confirmation from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The certificate confirms that securities received from depository participants for dematerialisation during the specified quarter were processed and listed on the stock exchanges. It also states that the security certificates received were duly verified, cancelled, and the depositories were substituted in the company's register of members within the prescribed timelines.

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, issued the confirmation. The registered address of the registrar is C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083. The company has requested that this information be taken on record.

Filing to action

What to do with a filing like this

Camlin Fine Sciences Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Camlin Fine Sciences Limited. Read the original for the full detail.

View original filing